Vertical Peak Holdings Inc (SPLIF)
0.004
0.00 (0.00%)
USD |
OTCM |
Mar 27, 16:00
Vertical Peak Holdings Cash from Investing (TTM): 0.619M for April 30, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
April 30, 2023 | 0.619M |
January 31, 2023 | 0.1451M |
October 31, 2022 | 0.4925M |
July 31, 2022 | 1.138M |
April 30, 2022 | 2.708M |
January 31, 2022 | 2.598M |
October 31, 2021 | 2.225M |
July 31, 2021 | 1.744M |
April 30, 2021 | 0.4979M |
January 31, 2021 | 0.4478M |
October 31, 2020 | 0.4515M |
July 31, 2020 | 0.0259M |
April 30, 2020 | -2.228M |
January 31, 2020 | -3.102M |
October 31, 2019 | -2.490M |
July 31, 2019 | 1.252M |
Date | Value |
---|---|
April 30, 2019 | 0.1788M |
January 31, 2019 | -2.285M |
October 31, 2018 | -2.424M |
July 31, 2018 | -5.838M |
April 30, 2018 | -1.984M |
January 31, 2018 | -1.896M |
October 31, 2017 | -3.105M |
July 31, 2017 | -3.360M |
April 30, 2017 | -4.442M |
January 31, 2017 | -1.215M |
October 31, 2016 | -0.8463M |
July 31, 2016 | -0.6725M |
April 30, 2016 | -0.4804M |
January 31, 2016 | -0.4341M |
October 31, 2015 | -0.8889M |
July 31, 2015 | -0.879M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-3.102M
Minimum
Jan 2020
2.708M
Maximum
Apr 2022
0.3943M
Average
0.4925M
Median
Oct 2022
Cash from Investing (TTM) Benchmarks
Acasti Pharma Inc | -1.452M |
Aurinia Pharmaceuticals Inc | -6.706M |
Edesa Biotech Inc | 0.00 |
Lexaria Bioscience Corp | -0.1748M |
Xenon Pharmaceuticals Inc | -117.17M |